Mitochondrial DNA (mtDNA) is known for high mutation rates caused by lack of protective histones, inecient DNA repair systems, and continuous exposure to mutagenic eects of oxygen radicals. We examined the frequency of mutations in the mtDNA D-Loop region in 20 patients with Barrett's carcinoma and associated Barrett's epithelium by automated DNA sequencing. Mutations were detected in eight of 20 (40%) patients in tumor and/or tumor-associated Barrett's epithelium. In six of eight positive cases, the mutations were detected only in the tumor, one of eight showed mutations in tumor and Barrett's epithelium, and one of eight only in Barrett's epithelium. The degree of dysplasia in Barrett's epithelium was classi®ed low-grade in one and high grade in the two specimens. There was no association of mtDNA D-Loop mutations with histopathological stage of disease or tumor grading. We present the ®rst study of frequent occurrence of mutations in the mtDNA D-Loop regions in adenocarcinomas in Barrett's esophagus. Furthermore, this study supports the hypothesis that oxidative damage might be a mechanism for the induction of adenocarcinoma in Barrett's esophagus. Since mutations were identi®ed in tumor-associated dysplastic Barrett's epithelium, they also might become a marker for the malignant potential of Barrett's epithelium. Oncogene (2002) (Wallace, 1994) . The human mtDNA is a double-stranded circular molecule of 16569 bp and contains 37 genes coding for two rRNAs, 22 tRNAs and 13 polypeptides (Anderson et al., 1981; Taanman, 1999) . The mtDNA is present in high copy levels (10 3 ± 10 4 copies per cell) in virtually all cells, and the vast majority of copies are identical at birth (Lightowlers et al., 1997) . Furthermore, mtDNA is known for having high acquired mutation rates. The mutation rate for mtDNA is around 10 times higher than that of nuclear genomic DNA (Wallace, 1994) . It is generally accepted that high mutation rates of mtDNA are caused by a lack of protective histones, inecient DNA repair systems, and continuous exposure to mutagenic eects of oxygen radicals generated by oxidative phosphorylation (Wallace, 1992a,b) . An association between mtDNA mutations and neurologic or metabolic disorders has previously been reported (Wallace 1992a; Gerbitz et al., 1995; Armstrong et al., 2000) .
Recently, mtDNA mutations were reported to occur in human cancers (Burgart et al., 1995; Alonso et al., 1997; Polyak et al., 1998; Tamura et al., 1999; Habano et al., 1999 Habano et al., , 2000 Fliss et al., 2000) . Alonso et al. (1997) detected mutations in the mtDNA displacementloop (D-Loop) region in colorectal and gastric malignancies. The D-Loop region is the major control site for mtDNA expression because it contains the leading-strand for origin of replication and major promoters for transcription (Taanman, 1999) . Nucleotide positions 16 024 ± 16 324 and 63 ± 322 located in the D-Loop are termed ®rst hypervariable region (HV1) and second hypervariable region (HV2), respectively (Miller et al., 1996) . The sequence analysis of these two regions is used not only in forensic analyses, but also in medical diagnosis (Levin et al., 1999) . Fliss et al. (2000) suggested that the constitutive hypervariable areas such as the mtDNA D-Loop are hot spots for somatic mutations in malignant tumors.
Frequent mutations have predominantly been reported for the p53 tumor-suppressor-gene in Barrett's cancer (Schneider et al., 1996 (Schneider et al., , 2000 . Mutations in the mtDNA have not been examined in Barrett's cancer so far but might occur frequently since oxygen radicals are known to be generated as a result of chronic in¯ammation in Barrett's esophagus (Olyaee et al., 1995) .
The purpose of this study was to evaluate the mutation frequencies in the two hypervariable regions (HV1 and HV2) of the mtDNA D-Loop region in patients with adenocarcinoma in Barrett's esophagus.
Twenty patients with adenocarcinoma in Barrett's esophagus were examined in this study. Barrett's carcinoma was de®ned as an adenocarcinoma originating above the gastroesophageal junction in association with characteristic specialized columnar mucosa. The length of tumor-associated Barrett's epithelium had to be 53 cm.
All patients received surgical resections. None of them received radiation therapy or chemotherapy prior to the operation. Histopathological tumor staging was performed according to the UICC Tumor-NodeMetastasis Classi®cation (Hermanek et al., 1992) and was distributed as follows: stage I, 10 (50%); stage II, seven (35%); stage III, three (15%). The histopathological grading of the primary tumor was classi®ed as well-dierentiated (G1) in one (5%), moderately dierentiated (G2) in seven (35%), and poorly dierentiated (G3) in 12 (60%) patients.
Tissue for DNA analysis was obtained by endoscopic biopsy or immediately after surgical resection and frozen in liquid nitrogen. Specimens were taken from the following locations: tumor (T), peritumoral Barrett's epithelium (BE-1) and Barrett's epithelium taken from the greatest distance to the tumor (BE-2). If there was only a small area of macroscopic tumorfree Barrett's epithelium, only peritumoral Barrett's epithelium (BE-1) could be harvested and analysed. The degree of dysplasia in Barrett's epithelium was evaluated according to the criteria of Riddell (1985) and simpli®ed to include only three categories as suggested by Williamson et al. (1991) : no evidence of dysplasia (NOD), low grade dysplasia (LGD), and high grade dysplasia (HGD). Thirty-one specimens of tumor-associated Barrett's epithelium were studied. The degree of dysplasia was determined as follows: NOD, 11 (35%); LGD, 12 (39%); HGD, eight (36%). Normal control tissue was taken from squamous epithelium of the esophagus and the gastric fundus.
Mutations in the mtDNA D-Loop regions in 20 patients with Barrett's carcinoma and associated Barrett's epithelium were monitored by automated DNA sequencing. Acquired mutations in the mtDNA D-Loop HV 1 and 2 regions were detected in eight of 20 (40%) patients in tumor and/or associated Barrett's epithelium when compared to normal squamous epithelium of the esophagus and gastric fundus. In six of eight positive cases, the mutations were detected only in the tumor, one of eight showed the mutation in tumor and Barrett's epithelium, and one of eight showed the mutation only in Barrett's epithelium (Table 1 and Figure 1) .
The presence of mtDNA mutations was not associated with the pT and pN categories, histopathological tumor stage or grading (Table 2) .
Three specimens of Barrett's epithelium showed mtDNA D-loop mutations. They were detected in the tumor, peritumoral and distant Barrett's epithelium in one patient and only in peritumoral Barrett's epithelium in the second patient. The degrees of dysplasia were high grade dysplasia (HGD) and low grade dysplasia (LGD) in one and HGD in the second patient. Heerdt et al. (1994) analysed the mutations of the H and L strand promoter region of mtDNA D-Loop (nucleotide position 371 ± 570) in 24 patients with colon cancer and did not ®nd any mutations. Tamura et al. (1999) analysed the mutations of the mtDNA D-Loop region including HV1 and HV2 in 45 Japanese patients with gastric cancer, and found mutations in 4% of the tumors. Conversely, Alonso et al. (1997) detected mutations in the mtDNA D-Loop region in 23% colorectal tumors and 37% gastric tumors. Fliss et al. (2000) analysed mutations in mtDNA in bladder, head and neck, and lung cancer. They detected mutations of mtDNA in 50% of cancers. In addition, 67% of T to C (310) C to T (308) T to C (310) C to G (314) T to C (310) C to T (311) 7 ( 7) ( 7) C to T (310) T to C (311) 8 ( 7) (Alonso et al., 1997) . However, frequencies might vary between dierent tumor entities (Alonso et al., 1997; Fliss et al., 2000) . Fliss et al. (2000) concluded that the detection of mtDNA mutations may provide a powerful molecular screening marker for the detection of cancer in bodȳ uids. Likewise, our study suggests that this technology might be a useful method for the detection of Barrett's cancer in small tissue samples including brush biopsies.
In the present study, we detected the mutations of mtDNA not only in Barrett's cancer, but also in tumor-associated Barrett's epithelium. All of the positive specimens of Barrett's epithelium had low or high grade of dysplasia. However, three types of mutations in the mtDNA D-Loop region were observed: the presence of mtDNA mutations only in tumor, in both tumor and Barrett's epithelium and the presence in Barrett's epithelium only. The occurrence of mtDNA mutations in the tumor or tumor and Barrett's epithelium is consistent with a process of clonal evolution (Norwell, 1976) . Reid et al. (1996) reported evidence using¯ow cytometry in a prospective study in patients with Barrett's esophagus that progression to adenocarcinoma is associated with a clonal evolution process. On the other hand, the presence of mtDNA mutation only in Barrett's epithelium could be explained with the ®eld cancerization theory (Slaughter et al., 1954) , implying that metaplastic Barrett's epithelium of these patients would be at increased risk for cancer development. Multiple areas of various degrees of dysplasia can exist in the same patient with Barrett's esophagus or Barrett's cancer, including the occurrence of multiple aneuploid cell populations (Reid et al., 1992; Neshat et al., 1994) , and progression to cancer in patients with Barrett's esophagus has been shown to be associated with increased genomic instability (Rabinovitch et al., 1989) . It is therefore likely that a mtDNA mutationnegative clone with a selective growth advantage formed a malignant tumor, and an area of Barrett's epithelium with an acquired mtDNA mutation was at an earlier step in the process of tumorigenesis. The similar phenomenon was observed in our previous study with p53 mutations in Barrett's cancer and tumor-associated epithelium (Schneider et al., 2000) .
Duodeno-gastro-esophageal re¯ux is supposed to play a role in the pathogenesis of Barrett's epithelium (Wetcher et al., 1998; Polkowski et al., 1999; Schrump and Nguyen, 1999) . Chen et al. (2000) suggested the important role of oxidative damage in the carcinogenesis of Barrett's carcinoma in a rat model. Furthermore, Olyaee et al. (1995) provided evidence for mucosal reactive oxygen species production in oesophagitis and Barrett's oesophagus. A high rate of oxidative damage of mtDNA compared to nuclear DNA was conclusively demonstrated (Richter et al., 1988) . We therefore hypothesize that continuous mucosal oxidative damage could be responsible for the observed mtDNA D-loop mutations in Barrett's cancer and tumor-associated Barrett's epithelium.
In conclusion, this is the ®rst study of frequent occurrence of mutations in the mtDNA D-Loop regions in patients with adenocarcinoma of Barrett's esophagus. This study provides further indirect Table 1 . The mutation was detected at nucleotide position 16093 (T to C transition). Arrows indicate the location of the point mutations. DNA was extracted from carefully selected specimens as previously described (Schneider et al., 2000) . Two sets of published primers L 15997/H 16401 and L 048/H 408 were purchased (MWG Biotech, Ebersberg, Germany) and used to amplify the HV1 and HV2 regions, respectively (Wilson et al., 1995) . Thermal cycling conditions were 5 min at 948C, followed by 32 cycles of 948C for 1 min, 608C for 1 min, and 728C for 1 min. The PCR product was separated by 2% agarose-gel electrophoresis in tris-acetate-EDTA (TAE) buer and visualized by ethidium-bromide staining. Before sequencing, the PCR product was puri®ed and separated from unreacted primers by ®ltration in a Centricon YM-100 device (Amicon Co., Bedford, MA, USA). Sequencing was performed using the Taq FS BigDye terminator cycle sequencing Kit (Applied Biosystems, Weiterstadt, Germany). The sequencing products were analysed on an ABI Prism TM 377 automated DNA sequencer (Applied Biosystems, Weiterstadt, Germany) mtDNA mutations in Barrett's cancer F Miyazono et al evidence that oxidative damage might be an important mechanism for the induction of adenocarcinoma in Barrett's esophagus. Furthermore, studies evaluating the role of mtDNA D-loop mutations as a marker for DNA damage and malignant potential in Barrett's epithelium seem justi®ed.
